Stay updated on Donafenib & KN046 Combo in GI Tumors Clinical Trial
Sign up to get notified when there's something new on the Donafenib & KN046 Combo in GI Tumors Clinical Trial page.

Latest updates to the Donafenib & KN046 Combo in GI Tumors Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new version entry v3.6.3 was added to the study's record history, replacing the previous v3.6.2 and reflecting an update to the history log.SummaryDifference0.1%

- Check22 days agoChange DetectedA new revision entry v3.6.2 was added to the record history and the previous v3.6.0 revision was removed, updating the revision trail to reflect the latest update.SummaryDifference0.1%

- Check36 days agoChange DetectedThe study page now shows no recruitment of participants, and the record version has been updated to v3.6.0, replacing the previous v3.5.5.SummaryDifference0.7%

- Check43 days agoChange DetectedNew revision entry v3.5.5 added to the study record history, replacing the previous v3.5.4 and signaling an update to the page.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page's revision indicator was updated to v3.5.4, replacing the previous v3.5.3, signaling a small update to the page metadata.SummaryDifference0.1%

- Check79 days agoChange DetectedThe study record now shows Terminated with the reason 'Due to R&D strategy adjustments; no safety issues involved,' with updated dates (2026-05-01 and 2026-04-27). It also adds sections for Study Status, Contacts/Locations, and Study Design, and removes older labels like Recruiting and the prior last-known status details.SummaryDifference2%

Stay in the know with updates to Donafenib & KN046 Combo in GI Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Donafenib & KN046 Combo in GI Tumors Clinical Trial page.